Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on July 28, 2026

Jul. 28, 2026

Rocket Doctor AI Inc. Announces Non-Brokered Private Placement of Unsecured Convertible Debentures

Indeterminate GlobeNewswire

Jul. 28, 2026

CISO Global Launches SurfaceWatch™ to Reveal External Cyber Risks Before They Become Incidents

Indeterminate GlobeNewswire

Jul. 28, 2026

Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments

Indeterminate GlobeNewswire

Jul. 28, 2026

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 28, 2026

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Indeterminate GlobeNewswire

Jul. 28, 2026

Aligned Data Centers Completes $1.18 Billion Securitization Financing

Indeterminate GlobeNewswire

Jul. 28, 2026

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 28, 2026

Banzai Announces OpenReel Creator AI: Edit Professional Video by Describing What You Want

Indeterminate GlobeNewswire

Jul. 28, 2026

Sent Raises $12M Series A to Supercharge AI Messaging Infrastructure

Indeterminate GlobeNewswire

Jul. 28, 2026

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Indeterminate GlobeNewswire

Jul. 28, 2026

AirJoule Technologies Deploys AirJoule™ Core System at GE Vernova’s New Advanced Research Center Frontier Campus

Indeterminate GlobeNewswire

Jul. 28, 2026

Enlivex Announces $400,000,000 Private Placement

Indeterminate GlobeNewswire

Jul. 28, 2026

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Indeterminate GlobeNewswire

Jul. 28, 2026

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial

Indeterminate GlobeNewswire

Jul. 28, 2026

Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance

Indeterminate GlobeNewswire

Jul. 28, 2026

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

Indeterminate GlobeNewswire

Jul. 28, 2026

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

Indeterminate GlobeNewswire

Jul. 28, 2026

Trevi Therapeutics to Participate in Upcoming August Conferences

Indeterminate GlobeNewswire

Jul. 28, 2026

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Indeterminate GlobeNewswire

Jul. 28, 2026

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

Indeterminate GlobeNewswire